![Michael Dunn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Dunn
President at
CALCIMEDICA, INC.
Net worth: 3 810 $ as of 29/09/2026
Profile
Michael J.
Dunn is currently Director at Arisan Therapeutics, Inc. and President & Chief Operating Officer at CalciMedica, Inc. since 2020.
Former positions include Director at Aegea Biotechnologies, Inc. from 2012 to 2017; Vice President-Business Development at Sibia Neurosciences, Inc.; Chief Business Officer & Vice President at Monogram Biosciences, Inc.; SVP-Corporate Development & Business Development at Biocept, Inc. from 2011 to 2013; Chief Business Officer & Vice President at ACLARA Biosciences, Inc. from 2003 to 2004; Vice President-Business Development at Aurora Biosciences Corp.
from 1998 to 2002; Chief Business Officer & Vice President at ActivX Biosciences, Inc. from 2002 to 2003; and President & Senior VP-Corporate Development at CalciMedica Subsidiary, Inc. Education includes undergraduate studies at The University of Chicago and an MBA from the University of San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CALCIMEDICA, INC. 0.03% | 23/06/2025 | 2,352 ( 0.03% ) | 3 810 $ | 29/09/2026 |
Michael Dunn active positions
| Companies | Position | Start |
|---|---|---|
| CALCIMEDICA, INC. | President | 31/12/2013 |
Arisan Therapeutics, Inc.
 Arisan Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutic for the treatment of neglected and emerging infectious diseases | Director/Board Member | - |
Former positions of Michael Dunn
| Companies | Position | End |
|---|---|---|
Aegea Biotechnologies, Inc.
 Aegea Biotechnologies, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic testing services | Director/Board Member | 31/12/2016 |
| BIOCEPT, INC. | Corporate Officer/Principal | - |
ACLARA Biosciences, Inc.
 ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology Discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic and oncologic diseases | Corporate Officer/Principal | 30/11/2004 |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Corporate Officer/Principal | 31/03/2003 |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Corporate Officer/Principal | 28/02/2002 |
Education of Michael Dunn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
34
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Sibia Neurosciences, Inc.
 Sibia Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule therapeutics for disorders of the nervous system | Health Technology |
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology Discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic and oncologic diseases | Health Technology |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services for HIV treatment | Commercial Services |
Biocept, Inc.
 Biocept, Inc. Medical/Nursing ServicesHealth Services Develops and performs clinical laboratory tests to detection & analysis of tumor cells and cell-free DNA from cerebrospinal fluid | Health Services |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
Arisan Therapeutics, Inc.
Arisan Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutic for the treatment of neglected and emerging infectious diseases | Health Technology |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aegea Biotechnologies, Inc.
Aegea Biotechnologies, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic testing services | Health Services |
CalciMedica, Inc.
 CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Michael Dunn
